Waters Completes Combination with BD's Biosciences & Diagnostic Solutions Businesses
* Announces appointment of Claire M. Fraser, Ph.D., to its Board of Directors * Forms a global life sciences and diagnostics leader focused on high-volume testing in regulated applications * Announces formation of four divisions: Waters Analytical Sciences, Waters Biosciences, Waters Advance...
Waters and BD's Biosciences & Diagnostic Solutions Business to Combine, Creating a Life Science and Diagnostics Leader Focused on Regulated, High-Volume Testing
* Strong strategic fit that increases presence in multiple high-growth adjacencies and offers immediate commercial impact from Waters' proven execution model * Doubles Waters' total addressable market to approximately $40 billion, with 5-7% annual growth * Creates a combined company with ...
BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years
FRANKLIN LAKES, N.J., Dec. 2, 2020 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to invest approximately$1.2 billion over a 4-year period to expand and upgrade manufacturing capacity and technology for pre-fillab...
BD Launches New Point-of-Care System for HIV/AIDS Patients
-- Easy-to-use CD4 analysis platform tailored to meet the needs of resource-limited settings SAN JOSE, Calif., May 6, 2014 /PRNewswire/ -- BD Biosciences, a segment of BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced the launch of the BD...
